News archive

Home News archive

ITTBioMed: the platform to enhance innovation and technology transfer

September 19, 2023 By Editorial Staff In Biology, Events, Pharmacology, R&D, Regulatory, Safety, Startup, Technologies
The weight of biotech in the pharmaceutical sciences is growing from 20% of the drugs produced in 2012 will constitute 80% in 2030. Italy is among the poles of excellence in Europe but must increase its attractiveness towards venture capital and encourage collaboration between public and private htt...

Top ten of the new finding published in 2024 on Nature Biotechnology

February 01, 2025 By Editorial Staff In R&D
top ten new finding 2024 nature biotechnology
From biotech financing to new drugs, from single-cell biology to advanced models for drug discovery: what were the most-read articles in Nature Biotechnology in 2024? Here is the ranking of the ten publications that captured the interest of the scientific and industrial community the most. 1. Biotec...

LIFE SCIENCES: presentation all the Projects Approved for Funding Under the Booster for Life Science FVG Notice | Proposal for Further Insights

January 20, 2025 By Editorial Staff In Events, Startup, Technologies
LIFE SCIENCES Discover the 22 Projects Approved for Funding Under the Booster for Life Science FVG Notice
On December 10th, the event dedicated to the presentation of the projects selected through the first call of the notice “Booster for Life Science – TRL Advancement” took place in Trieste.This initiative, promoted by the Life Sciences Cluster of Friuli Venezia Giulia on behalf of the Autonomous...

Amyloid Is Everywhere, but New Treatments Could Stop the Toxic Build Up

January 18, 2025 By Editorial Staff In R&D
proteine amiloidi
Amyloid deposits are not only present in the brains of cognitively impaired individuals but also accumulate throughout the body, impairing organ function and causing damage and disease. Therefore, the development of amyloid-targeting therapies has gained increasing attention, not only to treat Alzhe...